Callan JMB loss widens to $7.18M; going-concern warning
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
CALLAN JMB INC. reported third-quarter revenue of $1,146,699, down from $1,446,917 a year earlier; nine-month revenue was $3,629,167 versus $4,562,604. Nine-month net loss widened to $7,181,856 from $5,373,327, while nine-month operating cash use was $3,999,236. Cash and cash equivalents were $1,776,719 at September 30, 2026.
The company said substantial doubt about its ability to continue as a going concern within one year after the financial statements were issued was not alleviated. Its subsidiary’s $1,000,000 line of credit was fully drawn; maturity was extended from October 29, 2026 to January 27, 2027. In October 2026, CALLAN JMB completed an additional $4.0 million ELOC sale, with net proceeds of $3.66 million. The amended ELOC permits up to $75.0 million in common-stock sales, subject to a $1.00 closing-price floor for purchase notices and a 4.99% investor ownership cap.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointGoing-concern doubt remains; cash was $1,776,719 at September 30, 2026.
- Moderate pointNine-month revenue was $3,629,167, versus $4,562,604 a year earlier.
- Moderate pointNine-month net loss widened to $7,181,856 from $5,373,327.
Filing Explained
The separate ATM had not been used as of September thirtieth, so it had generated neither shares nor cash.
Callan JMB reports that its
Separately, the company could sell up to
Key Figures
Key Terms
substantial doubt financial
Equity Line of Credit (ELOC) financial
derivative liability financial
cost-to-cost method financial
anti-dilutive financial
net realizable value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the purchase limits and pricing rules for CJMB’s amended ELOC?
What are the interest rate and maturity of CJMB’s line of credit?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the quarterly period ended
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ____________ to ____________
Commission
file number:
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) |
(Address of principal executive offices, including zip code)
Tel:
(Registrant’s telephone number, including area code)
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☐ NO ☒
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. YES ☐ NO ☒
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and emerging growth company in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| ☒ | Smaller reporting company | ||
| Emerging growth company |
If
an emerging growth company, indicate by check mark if this registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark
whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☒
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate
by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
As
of November 13, 2026, the Company had
Documents Incorporated by Reference: None.
CALLAN JMB INC.
FORM 10-Q
TABLE OF CONTENTS
| PART I | ||
| Item 1. | Unaudited Financial Statements | |
| Condensed Consolidated Balance Sheets as of September 30, 2026 (unaudited) and December 31, 2025 | 3 | |
| Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (unaudited) | 4 | |
| Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2026 and 2025 (unaudited) | 5 | |
| Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (unaudited) | 6 | |
| Notes to Condensed Consolidated Financial Statements | 7 | |
| Item 2. | MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL AND RESULTS OF OPERATIONS | 30 |
| Item 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 34 |
| Item 4. | CONTROLS AND PROCEDURES | 34 |
| PART II | ||
| Item 1. | LEGAL PROCEEDINGS | 35 |
| Item 1A. | RISK FACTORS | 35 |
| Item 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS | 35 |
| Item 6 | EXHIBITS | 36 |
| SIGNATURES | 37 | |
| 2 |
CALLAN JMB INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
| September 30, 2026 (Unaudited) | December 31, 2025 | |||||||
| Assets | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Accounts receivable, net of allowance for credit losses of $ | ||||||||
| Inventory | ||||||||
| Other current assets | ||||||||
| Deferred offering costs | - | |||||||
| Total current assets | ||||||||
| Right of use assets - operating lease | ||||||||
| Advances to affiliates | - | |||||||
| Property and equipment, net of accumulated depreciation of $ | ||||||||
| Total assets | $ | $ | ||||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued expenses | ||||||||
| Corporate taxes payable | ||||||||
| Right of use liabilities – operating lease | ||||||||
| Line of Credit | - | |||||||
| Derivative liability | - | |||||||
| Total current liabilities | ||||||||
| Right of use liabilities – operating lease | ||||||||
| Deferred Tax liability | - | |||||||
| Derivative liability | - | |||||||
| Total long-term liabilities | ||||||||
| Total liabilities | ||||||||
| Commitments and Contingencies – Note 9 | - | - | ||||||
| Stockholders’ Equity | ||||||||
| Preferred stock - authorized | $ | - | $ | - | ||||
| Common stock - authorized | ||||||||
| Additional Paid in Capital | ||||||||
| Accumulated Deficit | ( | ) | ( | ) | ||||
| Total Stockholders’ Equity | ||||||||
| Total Liabilities and Stockholders’ Equity | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 3 |
CALLAN JMB INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
| Three months ended | Nine months ended | |||||||||||||||
| September 30, 2026 | September 30, 2025 | September 30, 2026 | September 30, 2025 | |||||||||||||
| Revenue | $ | $ | $ | $ | ||||||||||||
| Cost of revenue | ||||||||||||||||
| Gross profit | ||||||||||||||||
| Operating expenses | ||||||||||||||||
| Selling, general and administrative expenses | ||||||||||||||||
| Operating loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other income (expenses) | ||||||||||||||||
| Interest income | ||||||||||||||||
| Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| ELOC facility transaction expenses | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Changes in fair value of derivative liability | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Total other income (expenses) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Loss before income taxes | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Provision (benefit) for income taxes | ( | ) | - | |||||||||||||
| Net Loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average common shares outstanding - basic and diluted (See Note 2) | ||||||||||||||||
| Net loss per common share - basic and diluted (See Note 2) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 4 |
CALLAN JMB INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(UNAUDITED)
| Shares | Amount | Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid in | Accumulated | Total Stockholders’ | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||||||||
| January 1, 2026 | - | - | $ | $ | $ | ( | ) | $ | ||||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Issuance of ELOC Shares | - | |||||||||||||||||||||||||||
| Stock based compensation | - | - | - | - | - | |||||||||||||||||||||||
| Restricted stock unit awards vesting | ( | ) | - | - | ||||||||||||||||||||||||
| March 31, 2026 | - | $ | - | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Stock based compensation | - | - | - | - | - | |||||||||||||||||||||||
| Restricted stock unit awards vesting | ( | ) | - | - | ||||||||||||||||||||||||
| June 30, 2026 as previously reported | - | $ | - | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
| Immaterial revisions (See Note 11) | - | $ | - | $ | - | $ | ( | ) | $ | ( | ) | |||||||||||||||||
| June 30, 2026 as revised | - | $ | - | 5,664,868 | $ | 5,665 | $ | 15,383,189 | $ | (14,797,742 | ) | $ | 591,112 | |||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Stock based compensation | - | - | - | - | - | |||||||||||||||||||||||
| Restricted stock unit awards vesting | ( | ) | - | - | ||||||||||||||||||||||||
| Issuance of ELOC Shares | - | - | - | |||||||||||||||||||||||||
| Common stocks issued for professional services | - | - | - | |||||||||||||||||||||||||
| September 30, 2026 | - | $ | - | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
| Preferred Stock | Common Stock | Additional Paid in | Accumulated | Total Stockholders’ | ||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||||||||
| January 1, 2025 | - | $ | - | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Common stock issued in initial public offering, net of costs | - | - | - | |||||||||||||||||||||||||
| Common stock issued in initial public offering (over allotment), net of costs Stock based compensation | - | - | - | |||||||||||||||||||||||||
| Stock based compensation | - | - | - | - | - | |||||||||||||||||||||||
| March 31, 2025 | - | $ | - | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
| Net Loss | - | - | - | - | - | ( | ) | ( | ) | |||||||||||||||||||
| Stock based compensation | - | - | - | - | - | |||||||||||||||||||||||
| Restricted stock unit awards vesting | - | - | ( | ) | - | - | ||||||||||||||||||||||
| June 30, 2025 | - | $ | - | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
| Net Loss | - | - | $ | - | ( | ) | ( | ) | ||||||||||||||||||||
| Stock based compensation | - | - | - | - | - | |||||||||||||||||||||||
| Restricted stock unit awards vesting | - | ( | ) | - | - | |||||||||||||||||||||||
| Issuance of shares under the ELOC Facility (see Note 7) | - | - | - | |||||||||||||||||||||||||
| Issuance of ELOC Shares | - | - | - | |||||||||||||||||||||||||
| Commitment shares under ELOC Facility (see Note 7) | - | - | - | - | - | |||||||||||||||||||||||
| September 30, 2025 | - | $ | - | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 5 |
CALLAN JMB INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| For the Nine months ended | ||||||||
| September 30, 2026 | September 30, 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net Loss | $ | ( | ) | $ | ( | ) | ||
| Adjustment to reconcile net loss to net cash used in operating activities: | ||||||||
| Changes in fair value of derivative liability | ||||||||
| Depreciation and amortization | ||||||||
| Amortization of right-of-use assets | ||||||||
| Provision for credit losses | ||||||||
| Other non-cash expenses relating to ELOC Facility | ||||||||
| Common stocks issued for professional services | - | |||||||
| Stock based compensation | ||||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | ( | ) | ( | ) | ||||
| Inventory | ( | ) | ||||||
| Tax refund receivable | - | |||||||
| Other current assets | ( | ) | ( | ) | ||||
| Operating lease liabilities | ( | ) | ||||||
| Accounts payable and accrued expenses | ( | ) | ||||||
| Deferred revenue | - | ( | ) | |||||
| Deferred tax liability | ( | ) | ||||||
| Corporate taxes payable | ( | ) | ||||||
| Net cash used in operating activities | $ | ( | ) | $ | ( | ) | ||
| Cash flows used in investing activity | ||||||||
| Purchase of property and equipment | ( | ) | ( | ) | ||||
| Net cash used in investing activity | $ | ( | ) | $ | ( | ) | ||
| Cash flows from (used in) financing activities: | ||||||||
| Related party loans | - | |||||||
| Deferred offering costs | ( | ) | ||||||
| Advances to affiliate | ( | ) | - | |||||
| Proceeds from IPO and overallotment, net | - | |||||||
| Proceeds from line of credit | - | |||||||
| Proceeds from offering of ELOC Facility | - | |||||||
| Proceeds from issuance of shares under the ELOC Facility | - | |||||||
| Net cash from financing activities | $ | $ | ||||||
| Increase (decrease) in cash and cash equivalents | ( | ) | ||||||
| Cash and cash equivalents at beginning of period | ||||||||
| Cash and cash equivalents at end of period | $ | $ | ||||||
| For the Nine months ended | ||||||||
| September 30, 2026 | September 30, 2025 | |||||||
| Supplemental disclosures of cash flow information: | ||||||||
| Cash paid for interest | $ | $ | ||||||
| Lease incentives reimbursement | $ | |||||||
| Supplemental disclosures of Non-Cash Financing and Investing Activities: | ||||||||
| Initial recognition of derivative liability | $ | - | $ | |||||
| Right of use assets acquired and operating lease liabilities recognized for new lease arrangement | $ | $ | ||||||
| Right of use assets and operating lease liabilities due to lease modifications | $ | - | $ | |||||
| Fair value of Stock Warrants issued at IPO | $ | - | $ | |||||
| Deferred offering costs charged to additional paid-in-capital | $ | - | $ | |||||
| Restricted stock unit awards vesting (par value) | $ | $ | ||||||
| Other non-cash expenses relating to ELOC Facility | $ | - | $ | |||||
| Issuance of common stock for ELOC-related consideration and expenses | $ | $ | - | |||||
| Commitment shares under ELOC Facility | $ | - | $ | |||||
| Common stocks issued for professional services | $ | $ | - | |||||
| Income taxes paid | $ | $ | - | |||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 6 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 – NATURE OF OPERATIONS
Callan
JMB Inc. (which may be referred to as “Callan,” “Callan JMB,” “CJMB”, “Company,”
“we,” “us,” or “our”) was formed on January 24, 2024, in the state of Nevada for the purposes of
reorganizing and becoming a holding company for Coldchain Technology Services, LLC and Callan JMB Services (India) Private Limited.
CTS was formed on December 27, 2006, in the state of Texas and is our main operating subsidiary engaged in a vertically integrated
logistics and fulfillment ecosystem that utilizes advanced predictive technology for the supply chain by guaranteeing the safety,
effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time sensitive
industries while ensuring environmental responsibility. Callan JMB Services (India) Private Limited is domiciled in Pune,
Maharashtra, India and is
The interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2025 and notes thereto contained in the Company’s Form 10-K filed with the Securities and Exchange Commission.
Going Concern
The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and other commitments in the normal course of business. As such, the financial statements do not include adjustments for the recoverability and classification of assets and their carrying amounts, or for the amount and classification of liabilities that may result should the Company be unable to continue as a going concern.
As
of September 30, 2026, the Company had an accumulated deficit of $(
On
July 29, 2026, the Company’s subsidiary, Coldchain Technology Services, LLC (“CTS”), entered into a $
| 7 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1 – NATURE OF OPERATIONS (CONTINUED)
Management considered the above circumstances and current maturity of line of credit, together with the Company’s cash on hand at September 30, 2026 stated above and its projected operating cash flows, in evaluating the Company’s ability to meet its obligations as they become due within one year after the date these financial statements are issued. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. As a result of the conditions identified and the uncertainty regarding the achievability of management’s plans, substantial doubt about the Company’s ability to continue as a going concern has not been alleviated.
Since
inception, the Company has funded its operations through operating cash flows, the ELOC Facility, and capital contributions or other
funding from the Company’s CEO and largest shareholder. Management will continue to evaluate additional sources of capital, including
equity and debt financing and support from the Company’s Chief Executive Officer and largest shareholder. In October 2026, the
Company completed an additional $
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation and Basis of Presentation
The Condensed Consolidated Financial Statements include all of the accounts of the Company and our subsidiaries. We have eliminated all significant intercompany transactions and balances in consolidation. In management’s opinion, all adjustments, consisting only of normal recurring accruals, necessary for a fair statement of our Condensed Consolidated Balance Sheet as of September 30, 2026, and our Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 have been made. The results set forth in our Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and in our Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the full year. The Condensed Consolidated Balance Sheet as of December 31, 2025 was derived from audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States (“GAAP”).
Reclassifications
Certain prior year amounts in the Consolidated Financial Statements and the notes thereto have been reclassified where necessary to conform to the current period’s presentation. These reclassifications did not affect the prior period’s total assets, total liabilities, stockholders’ equity, net income, or net cash used in operating and investing or net cash from financing activities.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements and the accompanying notes. Management bases its estimates on historical experience and other assumptions that it believes to be reasonable at the time. Actual results could differ from those estimates and any such differences may be material to the financial statements. Significant estimates are contained in the accompanying financial statements for the useful lives for depreciation and amortization of long-lived assets, allowance for credit losses, fair value of derivative liability, stock based compensation and the incremental borrowing rate used in determining the right-of-use assets and operating lease liabilities.
Cash and Cash Equivalents
The Company considers all highly
liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents. The
Company deposits its cash with high credit quality financial institutions. The Company’s accounts at these institutions are
insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $
| 8 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Accounts Receivable
Accounts receivable are recorded at the invoiced amount, which is the amount the Company expects to collect from its customers. Generally, payment is due from customers within 30-90 days of the invoice date. On a regular basis, the Company evaluates its accounts receivable and establishes the allowance for credit losses based on an evaluation of certain criteria and evidence of collection uncertainty including historical collection trends, reasonable expectations of future collections, current economic trends and changes in customer payment patterns. Past-due receivable balances are written off when the Company’s collection efforts have been deemed unsuccessful. The Company maintains an allowance for credit losses to reserve for potential uncollectible receivables. The allowance for credit losses as of September 30, 2026 and December 31, 2025 are as follows:
SCHEDULE OF ALLOWANCE FOR CREDIT LOSSES
| September 30, 2026 | December 31, 2025 | |||||||
| Beginning balance | $ | $ | ||||||
| Provision for credit losses | ||||||||
| Related allowances for written off accounts receivable | - | ( | ) | |||||
| Reversal of allowance related to reinstated invoices previously charged off | - | ( | ) | |||||
| Others | - | |||||||
| Ending balance | $ | $ | ||||||
Credit Concentration
The concentration of credit risks in accounts receivable is due to certain large customers comprising the Company’s customer base throughout North America. The Company maintains policies over credit extension that include credit evaluations, credit limits and collection monitoring procedures on a customer-by-customer basis. However, the Company generally does not require collateral before services are performed.
The Company has two customers for the three and nine months ended September 30, 2026 and 2025 that make up in excess of 10% of revenue as follows:
SCHEDULE OF CONCENTRATION OF RISK
| Three Months Ended | Nine months ended | |||||||||||||||
| Customer | September 30, 2026 | September 30, 2025 | September 30, 2026 | September 30, 2025 | ||||||||||||
| 1 | % | % | % | % | ||||||||||||
| 2 | % | % | % | % | ||||||||||||
| 9 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
The Company has several customers as of September 30, 2026 and December 31, 2025 that make up in excess of 10% of accounts receivable as follows:
| Customer | 2026 | 2025 | ||||||
| 1 | % | % | ||||||
| 2 | % | % | ||||||
| 3 | % | % | ||||||
The Company has three vendors as of September 30, 2026 and December 31, 2025 that make up in excess of 10% of accounts payable as follows:
| Vendor | 2026 | 2025 | ||||||
| 1 | % | % | ||||||
| 2 | % | % | ||||||
| 3 | % | % | ||||||
The Company has one vendor for the nine months ended September 30, 2026 and 2025 that make up equal to or more than 10% of services rendered to us as follows:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| Vendor | September 30, 2026 | September 30, 2025 | September 30, 2026 | September 30, 2025 | ||||||||||||
| 1 | % | % | % | % | ||||||||||||
| Concentration risk percentage | % | % | % | % | ||||||||||||
Inventory
Inventory is stated at the lower of cost (using the first-in, first-out method (“FIFO”)) or net realizable value. We continually analyze our slow moving and excess inventories. Based on historical and projected sales volumes and anticipated selling prices, we determined that establishing a reserve was not necessary at this time. Inventory that is in excess of current and projected use is reduced by an allowance to a level that approximates its estimate of future demand. Products that are determined to be obsolete are written down to net realizable value. The Company’s inventory is comprised of raw materials for customer packaging needs as follows:
SCHEDULE OF INVENTORY
| (Unaudited) | ||||||||
September 30, 2026 | December 31, 2025 | |||||||
| Raw materials | $ | $ | ||||||
Property and Equipment
Property and equipment, net, is stated at cost less accumulated depreciation. Expenditures for major renewals and improvements that extend the life or usefulness of the asset are capitalized. Items of an ordinary repair or maintenance nature are charged directly to operating expense as incurred. During the construction and development period of an asset, the costs incurred, including interest expense, are classified as construction-in-progress. When the asset is ready for its intended use, the asset is reclassified to an appropriate asset classification and depreciation, or amortization commences.
| 10 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Property and Equipment (Continued)
The Company depreciates and amortizes the capitalized cost of these assets, using the straight-line method, as follows:
SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES
Asset Classification:
Computer
equipment
Furniture
and fixtures
Leasehold improvements limited to lease term
The
Company recognized depreciation expense of $
The
Company tests for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. An
Revenue Recognition
The Company recognizes revenue when control of the promised goods or services is transferred to the Company’s customers. Revenue is recorded at the transaction price, which is the amount that reflects the consideration the Company expects to receive in exchange for providing the goods or services. The Company’s primary performance obligations in our contracts with customers are to provide services related to emergency preparedness or to deliver specialty packaging. Most of the Company’s revenues are for services, which are recognized over time as the related time and materials are incurred at contractually agreed-upon rates. Product revenues are recognized at a point in time when the products are either shipped or delivered and control transfers to the customer. The Company’s payment terms vary by the type of customer and the products or services offered. The periods between invoicing and when payments are due are not significant. Amounts billed to customers related to shipping and handling are classified as revenue and the Company’s shipping and handling costs are included in costs of revenues.
Services Contracts
The Company provides services contract for a customer. For this contract, the Company’s performance creates an asset for the customer with no alternative use to the Company, and the Company has an enforceable right to payment for performance completed to date. Accordingly, the Company recognizes revenue over time as the performance obligation is satisfied. The Company measures progress toward completion using the cost-to-cost method, an input method. Under this method, revenue is recognized in proportion to costs incurred to date relative to total estimated costs at completion. The Company believes this method best depicts the transfer of control to the customer because costs incurred are directly proportional to the Company’s progress in satisfying the performance obligation. Contract costs include direct materials, direct labor, subcontractor costs, and other costs directly related to contract performance.
Recognizing revenue under the cost-to-cost method requires estimates of total contract costs, expected margin, and progress to date. Changes in estimates, including contract modifications, are recognized on a cumulative catch-up basis in the period in which the change becomes known. If estimated costs at completion exceed the transaction price, the full anticipated loss is recognized in the period it becomes evident.
Amounts billed or collected in excess of revenue recognized are recorded as contract liabilities within deferred revenue. Revenue recognized in excess of amounts billed is recorded as a contract asset.
Disaggregation of Revenue
The following table presents our disaggregated revenues by distribution channel:
SCHEDULE OF DISAGGREGATED REVENUES
| Sales by distribution channel: | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| Sales by distribution channel: | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Emergency preparedness | $ | $ | $ | $ | ||||||||||||
| Specialty packaging | ||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||
| Revenue | $ | $ | $ | $ | ||||||||||||
| 11 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
| Sales by customer type: | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| Sales by customer type: | 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Governmental | $ | $ | $ | |||||||||||||
| Non-governmental | ||||||||||||||||
| Total | $ | $ | $ | |||||||||||||
| Revenue | $ | $ | $ | |||||||||||||
Emergency preparedness
We provide comprehensive services primarily to state and local governments. These services include managing their building sites, medical stockpiles of equipment, supplies and responding to state or local emergencies. We also provide Quality Control/Assurance to safeguard vaccines, medical supplies, and equipment. Revenue is recognized when services are rendered, or medical supplies are shipped or delivered.
Specialty Packaging
Our specialty temperature-regulating packaging solutions provide a better thermal system to maintain and protect products and ensure peak customer experience. In utilizing this packaging, customers yield the benefits of lower costs and overhead while improving process, agility, velocity, accuracy, and repeatability of complex fulfillment networks. Revenue is recorded when products are delivered, or services are rendered. Additionally, it also includes amounts billed to customers related to shipping and handling are classified as revenue and the Company’s shipping and handling costs are included in costs of revenues as well as the Company’s contract with a customer for cloud-based temperature monitoring software. The customer paid their contract in advance and therefore revenue is earned monthly over the term of the contract.
Stock Warrants
During
the first quarter ended March 31, 2025, the Company granted
| 12 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Stock-Based Compensation
The Company provides stock-based compensation to its employees, professional service vendor and Board of Directors. The Company is required to exercise judgment and make estimates when determining the (i) fair value of each award granted and (ii) projected number of awards expected to vest. The Company calculates the fair value of all stock-based awards at the date of grant using the Black-Scholes option-pricing model for stock options, date of grant using the common stock price for restricted stock units and Monte Carlo simulation model for market-based awards. The Company uses the straight-line method to amortize this fair value as compensation cost over the requisite service period. Any forfeitures are recognized as they occur.
Net Loss per Common Share
The following table sets forth the number of potential shares of common stock that have been excluded from diluted net loss per share because their effect was anti-dilutive for the nine months ended September 30, 2026 and September 30, 2025:
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE
| (Unaudited) | ||||||||
| Nine Months Ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| Stock Options | ||||||||
| Restricted Stock Awards | ||||||||
| Stock Warrants | ||||||||
| Contingently shares issuable under ELOC Facility (settlement shares) | - | |||||||
| Total | ||||||||
Under the ELOC Facility, the Company delivers pre-settlement shares upon each purchase notice, and a variable number of additional shares to be settled after the reporting period. Pre-settlement shares are included in basic net loss per share and the additional shares above the pre-settlement shares are contingently issuable shares: they are excluded from basic net loss per share until the final number of shares to be delivered and all necessary conditions are satisfied. Because the Company reported a net loss, these shares were anti-dilutive and excluded from diluted net loss per share.
Cost of Revenues
Our cost of revenue primarily includes the amounts paid to outside service providers, monitoring, direct and indirect labor, warehouse rent and other related expenses.
Advertising Expense
Advertising
costs primarily consist of trade shows, other promotional expenses and the cost to retain our marketing firm. Advertising costs are expensed
as incurred. Advertising expense for the three months ended September 30, 2026 and 2025 was $
| 13 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Fair Value of Financial Instruments
The Company accounts for its derivative instruments in accordance with the provisions of Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging, which, among other things, establishes accounting and disclosure requirements for derivative instruments. The fair value of the instruments under ASC 820-10, Fair Value Measurement, which among other things provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I measurement) and the lowest priority to unobservable inputs (Level III measurements). The three levels of fair value hierarchy under ASC 820-10, Fair Value Measurement, are as follows:
Level I - Quoted prices are available in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level II - Significant observable inputs other than quoted prices in active markets for which inputs to the valuation methodology include: (1) Quoted prices for similar assets or liabilities in active markets; (2) Quoted prices for identical or similar assets or liabilities in inactive markets; (3) Inputs other than quoted prices that are observable; and (4) Inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the Level II input must be observable for substantially the full term of the asset or liability.
Level III - Significant unobservable inputs that reflect an entity’s own assumptions that market participants would use in pricing the assets or liabilities.
The asset or liability fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
The Company’s financial instruments primarily consist of cash and cash equivalents, accounts receivable, accounts payable and derivative liabilities.
The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate their respective fair values because of the short-term maturities or expected settlement dates of these instruments.
The
derivative liability as of September 30, 2026 and December 31 2025 are $
SCHEDULE OF DERIVATIVE LIABILITY
| September 30, 2026 | Level 1 | Level 2 | Level 3 | |||||||||||||
| Derivative liability at fair value | $ | $ | — | $ | — | $ | ||||||||||
| Total liability measured at fair value | — | — | ||||||||||||||
| 14 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Income Tax
The Company provides for income taxes and the related accounts under the asset and liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates expected to be in effect during the year in which the basis differences reverse. Valuation allowances are established when management determines it is more likely than not that some portion, or all, of the deferred tax assets will not be realized.
Leases
The Company’s leases predominantly relate to real estate and equipment, such as vehicles and industrial equipment utilized in operations. Contracts are reviewed at inception to determine if the arrangement is a lease. The Company generally enters into long-term real estate leases with one to ten-year terms. In the normal course of business, the Company also enters into short-term leases having terms of one year or less. These leases are generally equipment leases entered into for short periods of time (e.g., daily, weekly, or monthly) to satisfy immediate and/or short-term operational needs of the business which can arise based upon the nature of particular services performed. The Company has elected not to recognize right-of-use (“ROU”) assets and lease liabilities for these short-term leases. Operating leases with terms exceeding one year are recognized as ROU assets and lease liabilities and measured at the commencement date based on the present value of the future lease payments over the lease term. Certain of the Company’s real estate leases contain escalating future lease payments. Escalating lease payments that are based upon explicit amounts contained in the lease or an index (e.g., consumer price index) are included in the Company’s determination of future lease payments to determine the ROU asset and lease liability recognized at the commencement date. Any differences in the future lease payments from initial recognition are not anticipated to be material and will be recorded as variable lease cost in the period incurred. The variable lease cost will also include the Company’s portion of property tax, utilities, and common area maintenance. A significant portion of the Company’s real estate lease agreements include renewal periods at the Company’s option. The Company includes these renewal periods in the lease term only when renewal is reasonably certain based upon facts and circumstances specific to the lease and known by the Company. The Company uses its incremental borrowing rate available at the lease commencement date in determining the present value of future lease payments as the implicit rate is typically not readily determinable. For operating leases, lease cost is recognized on a straight-line basis over the lease term and is included in cost of revenues or selling, general and administrative expenses depending on the use of the asset. As of September 30, 2026 and December 31, 2025, the Company did not have any leases that were classified as finance leases.
| 15 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Recent Accounting Pronouncements
In November 2024, the FASB issued ASU 2024-03, Income Statement Reporting-Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40), Disaggregation of Income Statement Expenses. The standard update improves the disclosures about a public business entity’s expense by requiring more detailed information about certain types of costs and expenses in the notes to the financial statements. The guidance will be effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The standard updates are to be applied prospectively, with the option to apply them retrospectively. We are currently evaluating the impact of the new standard’s disclosure requirements on our financial statements.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. This standard introduces a practical expedient for the application of the current expected credit loss (“CECL”) model to current accounts receivable and contract assets. ASU 2025-05 is effective for annual periods beginning after December 15, 2025 and interim periods within those annual periods. The Company adopted ASU 2025-05 for the fiscal year and interim period beginning January 1, 2026 and elected the practical expedient. The adoption did not have a material impact on the consolidated financial statements and related disclosures.
In December 2025, the FASB issued ASU No. 2025-11, “Interim Reporting – Narrow-Scope Improvements,” which is intended to improve the navigability of previous guidance and clarify when that guidance is applicable. Among other items, it establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is not intended to change the fundamental nature of interim reporting or expand or reduce current interim disclosure requirements. The guidance may be applied retrospectively or prospectively and will be effective for the Company for interim periods beginning in fiscal year 2028. The Company is currently evaluating the impact of this ASU but does not anticipate this adoption to have a material impact on the Company’s financial statements.
The FASB issues ASUs to amend the authoritative literature in ASC. There have been a number of ASUs to date, including those above, that amend the original text of ASC. Management believes that those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to us or (iv) are not expected to have a significant impact on our consolidated financial statements.
| 16 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 3- ACCRUED EXPENSES
Accrued expenses consist of the following:
SCHEDULE OF ACCRUED EXPENSES
| (Unaudited) | ||||||||
| September 30, | December 31, | |||||||
| 2026 | 2025 | |||||||
| Payroll and related costs | $ | $ | ||||||
| Credit card | ||||||||
| Professional Fees | ||||||||
| Insurance | - | |||||||
| Storage | ||||||||
| Other | ||||||||
| Total | $ | $ | ||||||
NOTE 4 – LINE OF CREDIT
On
July 29, 2026, Coldchain Technology Services, LLC (“CTS”), a subsidiary of the Company, entered into a Business Loan
Agreement and Promissory Note with First United Bank and Trust Co (the “Lender”) providing for a $
Borrowings
under the Line of Credit bear interest at a variable rate equal to the Wall Street Journal prime rate plus
The Line of Credit is secured by a first-priority security interest in substantially all of CTS’s inventory, chattel paper, accounts, equipment and general intangibles. In addition, the Line of Credit is secured by (i) a pledge of an investment account owned by The Sandra G. Croyle Living Trust and (ii) The Line of Credit is also guaranteed, on an unlimited basis, by four individuals who are related parties of the Company by virtue of their ownership interest and management roles with the company. The Line of Credit is further secured by the CEO’s personal deposit account and an investment account held by a trust of which management personnel is a trustee. The Company did not pay any consideration to the guarantors or the collateral providers in connection with these arrangements (Note 5).
The Line of Credit Agreement contains customary affirmative and negative covenants. CTS must (i) deliver quarterly financial statements with schedules within 45 days of each quarter-end and annual tax returns, (ii) obtain the Lender’s approval before incurring additional debt, (iii) maintain its primary operating deposit accounts with the Lender within 90 days of closing, and (iv) obtain the Lender’s consent before merging, consolidating, changing its business, selling collateral outside the ordinary course of business, or making distributions with respect to its capital accounts. Events of default include nonpayment, breach of covenants, defaults under other agreements, a material adverse change in the financial condition of CTS or any guarantor, and the Lender’s good-faith belief that it is insecure. Upon an event of default, the Lender may declare all amounts immediately due and payable. As of September 30, 2026, the Company was in compliance with all covenants under the Loan Agreement.
During
the three months ended September 30, 2026, CTS borrowed $
During
the three and nine months ended September 30, 2026, the Company recognized and paid interest expense of $
| 17 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 5 – RELATED PARTY TRANSACTIONS
Business Partner
Health
Hero America (“HHA”) is a related party by virtue of common ownership of the Company. There were no transactions with the
related party during the three months ended September 30, 2026. During the nine months ended September 30, 2026, the Company provided
certain labor services to HHA and recognized service revenue amounting to $
Cold
Chain Delivery Systems (“ CCDS”), who is a related party by virtue of common ownership of the Company. There were
Outlaw
Run Ranch (“ORR”) is a related party by virtue of common ownership of the Company. The Company pays $
Warehouse
Asset Management is a related party by virtue of common ownership. The Company leases its headquarters, warehouse, other warehouse equipment
and a box truck for $
During
the three months ended March 31, 2025 the Company awarded
Monarch
Property Management is a related party by virtue of common ownership of the Company. The Company paid for certain legal expenses, which
amounted to $
In
connection with the $
The Company has performed an analysis under ASC 810 and has determined that the afore-mentioned related parties do not qualify as a Variable Interest Entity and therefore those entities were not consolidated in the preparation of the accompanying financial statements.
| 18 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 6 - SEGMENTS
Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the Company’s Chief Operating Decision Maker (“CODM”) to make decisions with respect to resource allocation and assessment of performance. To date, the Company has viewed its operations and manages its business as one operating segment. The results of its operating segment are reviewed monthly by the Company’s Chief Executive Officer and President, who has been identified as the CODM.
The
CODM regularly assesses the performance of the
NOTE 7 - EQUITY
During
February 2025, we completed our initial public offering (“IPO”) of
| 19 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 7 – EQUITY (Continued)
During
the nine months ended September 30, 2026, the Company did not complete any public offerings of its common stock. Equity activity during
the quarter consisted of (i) the issuance of
As of September 30, 2026, the Company had the following equity awards outstanding:
| ● | Stock
options: |
| ● | RSUs:
|
| ● | Performance-based
RSUs: |
| ● | Market-based
RSUs: |
| ● | Underwriter
warrants: |
All outstanding RSUs, options and warrants remain subject to applicable vesting, lock-up and control restrictions.
Equity Line of Credit (ELOC)
On
July 24, 2025, the Company entered into an ELOC Purchase Agreement (“Equity Line of Credit,” or the “ELOC Facility”)
with an investor, whereby the Company has the right, but not the obligation, to sell to the investor therein, up to an aggregate of $
In
January 2026, the Company issued
| 20 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 7 – EQUITY (Continued)
On
March 10, 2026, the Company entered into an amendment to its ELOC Facility wherein it extended the maturity to April 1, 2027. Additionally,
certain amendments to the measurement period and the settlement price from
On
August 18, 2026, the Company and the ELOC Investor entered into a First Amended and Restated Purchase Agreement (the “Restated
Purchase Agreement”), which amends and restates in its entirety the ELOC Facility, as previously amended. The Restated Purchase
Agreement, among other changes: (i) increases the aggregate amount of common stock the Company may sell from $
During
the nine months ended September 30, 2026, the Company issued shares of common stock pursuant to the Equity Line of Credit
(“ELOC”) facility in connection with both current-period drawdowns and the final settlement of ELOC activity initiated
in a prior period. On August 20, 2026, the Company delivered an Exempt Purchase Notice to the ELOC Investor for $
The
Company has the right to terminate the ELOC Facility at any time after the Commencement Date, for any reason or for no reason by delivering
notice to the Investor electing to terminate the agreement without any liability except in the event the Company has sold less than $
| 21 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 7 – EQUITY (Continued)
Equity Line of Credit (ELOC) (Continued)
The ELOC Facility contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.
The Company accounted for its ELOC Facility as a purchased put option and is either equity-classified or liability-classified instruments based on an assessment of the agreement’s specific terms and applicable authoritative guidance in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815, “Derivatives and Hedging”. The assessment considers whether the purchased put option is a freestanding financial instrument that would require classification as a liability under ASC 480, as well as whether the purchased put option would qualify for equity classification or require a liability classification after consideration of the guidance and criteria outlined in ASC 815, including whether the purchased put option are indexed to the Company’s own common shares and whether the holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions that impact classification. The Company also assessed embedded features in the ELOC Facility under the ASC 480 and ASC 815 guidance, management believed that these embedded features were not freestanding and are clearly and closely related to the host contract and as such do not require bifurcation from the purchased put option. This assessment, which requires the use of professional judgment, is conducted at the time of agreement. The Company assessed that the purchased put option is not under the scope of ASC 480 but is a derivative liability under ASC 815 as it does not meet the scope exception, indexation guidance and equity classification criteria under ASC 815 due to certain variability to the settlement price. As such, the Company accounted for the purchased put option as a derivative liability recognized at fair value at the inception date and each reporting period.
The fair value of the purchased put option was estimated on the date of agreement using Monte Carlo Simulation Model with the following assumptions at each measurement date:
SCHEDULE OF FAIR VALUE ASSUMPTIONS
| Inception Date | September 30, 2026 | |||||||
| Expected life (in years) | ||||||||
| Expected stock price volatility | % | % | ||||||
| Risk-free interest rate | % | % | ||||||
| Stock Price | ||||||||
The risk-free interest rate was based on U.S. Treasury interest rates, the terms of which are consistent with the expected life of purchased put option. Expected volatility was derived using the Company’s peer volatility calculated from its peer companies’ volatilities over the time period commensurate with the expected life of the purchased put option. The expected life was calculated using the terms of the ELOC Facility.
| 22 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 7 – EQUITY (Continued)
Equity Line of Credit (ELOC) (Continued)
The
Company recognized the fair value of the purchased put option as of September 30, 2026, in its balance sheet under the caption, “Derivative
Liability.” The change in the fair value of the Derivative Liability during the nine months ended September 30, 2026, was $
SCHEDULE OF DERIVATIVE LIABILITY EQUITY LINE OF CREDIT
| September 30, 2026 | December 31, 2025 | |||||||
| Derivative liability at fair value – beginning balance | - | |||||||
| Recognition of derivative liability arising from ELOC facility | ||||||||
| Changes in fair value of derivative liability during the period | ( | ) | ||||||
| Derivative liability at fair value – ending balance | $ | $ | ||||||
The derivative liability related to the ELOC Facility,
the Company’s only Level 3 financial instrument measured at fair value on a recurring basis, was $
Registration Rights Agreements
In connection with the ELOC Facility, the Company also granted the Investor certain registration rights for shares of common stock issuable within the ELOC Facility, including (a) the ability of a holder to request that the Company file a Form S-1 registration statement; (b) the ability of a holder to request that the Company file a Form S-3 registration statement with respect to outstanding registrable securities if at any time the Company is eligible to use a Form S-3 registration statement; and (c) certain piggyback registration rights related to potential future equity offerings of the Company, subject to certain limitations.
On August 18, 2026, the Company restated the original agreement through
the First Amended and Restated Registration Rights Agreement. The Company is required to file a new registration statement covering the
resale of the additional shares issuable under the increased $
On
August 24, 2025, the Company filed a registration statement on Form S-1 related to the resale, from time to time, of up to
ATM Offering Program
On
May 26, 2026, the Company entered into an At-The-Market (“ATM”) Issuance Sales Agreement, pursuant to which the Company may
offer and sell shares of its common stock having an aggregate offering price of up to $
In
connection with the establishment of the ATM program, the Company incurred approximately $
NOTE 8 - SHARE BASED COMPENSATION
Overview
The Company grants share-based compensation awards to the Company’s employees as provided by the 2024 Equity Incentive Plan (“2024 Plan”), which was approved by the Company’s stockholders on October 24, 2024. The 2024 Plan provides that grants may be in any of the following forms: incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, and performance awards. The 2024 Plan will be administered and interpreted by the Compensation Committee of the Board of Directors. The Compensation Committee has the authority to determine the individuals to whom grants will be made under the 2024 Plan, determine the type, size and terms of the grants, determine the time when grants will be made and the duration of any applicable exercise or restriction period (subject to the limitations of the 2024 Plan) and deal with any other matters arising under the 2024 Plan. All the employees of the Company and its subsidiaries are eligible for grants under the 2024 Plan. Non-employee directors and consultants of the Company are also eligible to receive grants under the 2024 Plan.
| 23 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 8 - SHARE BASED COMPENSATION (CONTINUED)
Overview (Continued)
The
Company has reserved
During the three months and nine months ended
September 30, 2026, the Company entered into a professional service agreement with a third party wherein,
Stock Options
During
the nine months ended September 30, 2026, the Company granted
During
the nine months ended September 30, 2026, a certain former employee of the Company forfeited all of their remaining unvested options.
As the Company has elected to record forfeitures as they occur, the Company recognized a related reversal of its previously recognized
compensation expense for unvested stock option awards of $
A summary of nonstatutory stock option activity during the nine months ended September 30, 2026 is included below.
SUMMARY OF STOCK OPTIONS ACTIVITY
Number of Awards | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Term (in years) | Aggregate Intrinsic Value | |||||||||||||
| Outstanding at December 31, 2025 | - | |||||||||||||||
| Granted | - | |||||||||||||||
| Exercised | - | - | - | - | ||||||||||||
| Forfeited | - | - | - | - | ||||||||||||
| Outstanding at March 31, 2026 | - | |||||||||||||||
| Granted | - | - | - | - | ||||||||||||
| Exercised | - | - | - | - | ||||||||||||
| Forfeited | ( | ) | - | - | ||||||||||||
| Outstanding at June 30, 2026 | - | |||||||||||||||
| Granted | - | - | - | - | ||||||||||||
| Exercised | - | - | - | - | ||||||||||||
| Forfeited | - | - | - | - | ||||||||||||
| Outstanding at September 30, 2026 | - | |||||||||||||||
| Outstanding and Exercisable | - | |||||||||||||||
| 24 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 8 - SHARE BASED COMPENSATION (CONTINUED)
The fair value of each option granted was estimated on the date of grant using the Black-Scholes-Merton option-pricing model with the following assumptions:
SUMMARY OF FAIR VALUE OF OPTIONS
| 2026 | 2025 | |||||||
| Expected life (in years) | ||||||||
| Expected stock price volatility | % | % | ||||||
| Risk-free interest rate | % | % | ||||||
| Dividend rate | % | % | ||||||
The risk-free interest rate was based on U.S. Treasury interest rates, the terms of which are consistent with the expected life of the stock options. Expected volatility was derived using the Company’s peer volatility calculated from its peer companies’ volatilities over the time period commensurate with the expected life of the stock options. The expected life for the stock options granted was calculated using the midpoint assumption equal to the time from the grant date to the midpoint of the weighted average vesting date and the expiration date. The Company does not currently pay dividends on its common stock nor does it expect to in the foreseeable future.
The
weighted average grant date fair value of options granted during the nine months ended September 30, 2026 was $
Performance-Based Awards
During
the nine months ended September 30, 2025, the Company granted
Market-Based Awards
During
the nine months ended September 30, 2025, the Company granted
The fair value of each market-based awards granted was estimated on the date of grant using a Monte Carlo pricing model with the following assumptions:
SUMMARY OF FAIR VALUE OF EACH MARKET BASED AWARDS GRANTED
Grant date | ||||
| Derived service period (years) | ||||
| Dividend rate | - | % | ||
| Risk-free interest rate | % | |||
| Expected stock price volatility | % | |||
The risk-free interest rate was based on U.S. Treasury interest rates, the terms of which are consistent with the expected life of the market-based awards. Expected volatility was derived using the Company’s peer volatility calculated from its peer companies’ volatilities over the time period commensurate with the expected life of the market-based awards. The expected life for the market-based awards granted was calculated using the midpoint assumption equal to the time from the grant date to the midpoint of the weighted average vesting date and the expiration date. The Company does not currently pay dividends on its common stock nor does it expect to in the foreseeable future.
| 25 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 8 - SHARE BASED COMPENSATION (CONTINUED)
Market-Based Awards (Continued)
SUMMARY OF MARKET-BASED AWARDS
| Performance-Based | Market-Based | |||||||||||||||
Number of Awards | Weighted- Average Grant Date Fair Value | Number of Awards | Weighted- Average Grant Date Fair Value | |||||||||||||
|
Outstanding at January 1, 2026 | $ | $ | ||||||||||||||
Granted | - | - | - | - | ||||||||||||
| Change in units based on performance | - | - | - | - | ||||||||||||
| Forfeited | - | - | - | - | ||||||||||||
| Outstanding at March 31, 2026 | $ | $ | ||||||||||||||
| Granted | - | - | - | - | ||||||||||||
| Change in units based on performance | - | - | - | - | ||||||||||||
| Forfeited | - | - | - | - | ||||||||||||
| Outstanding at June 30, 2026 | $ | $ | ||||||||||||||
| Granted | - | - | - | - | ||||||||||||
| Change in units based on performance | - | - | - | - | ||||||||||||
| Forfeited | - | - | - | - | ||||||||||||
| Outstanding at September 30, 2026 | $ | $ | ||||||||||||||
Restricted Stock Units
During
the nine months ended September 30, 2026, the Company granted
SCHEDULE OF RESTRICTED STOCK UNITS
| September 30, 2026 | ||||||||
Number of Awards | Weighted Average Grant Date Fair Value | |||||||
| Beginning balance | $ | - | $ | - | ||||
| Issued RSUs during the period | ||||||||
| Vested RSUs during the period | ( | ) | ||||||
| Forfeited | ( | ) | - | |||||
| Remaining unvested RSUs | $ | $ | ||||||
| 26 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 8 - SHARE BASED COMPENSATION (CONTINUED)
Stock Warrants
The
grant date fair value of the Company’s stock warrants was $
SUMMARY OF FAIR VALUE OF STOCK WARRANTS
| Feb-25 | ||||
| Grant Date | ||||
| Expected life (in years) | ||||
| Expected stock price volatility | % | |||
| Risk-free interest rate | % | |||
| Dividend rate | % | |||
NOTE 9 - COMMITMENTS AND CONTINGENCIES
Operating Leases
The
Company has various leases that expire between now and 2036. The Company’s right-of-use assets and lease liabilities primarily
represent lease payments that are fixed at the commencement of a lease and variable lease payments that are dependent on an index or
rate. Lease payments are recognized as lease cost on a straight-line basis over the lease term, which is determined as the
non-cancelable period, including periods in which termination options are reasonably certain of not being exercised and periods in
which renewal options are reasonably certain of being exercised. The discount rate is determined using the Company’s estimated
incremental borrowing rate coinciding with the lease term at the commencement of a lease. The estimated incremental borrowing rate
for the Company was determined to be between
On
October 21, 2024, the Company entered into a long-term lease agreement for corporate office space with a third party. This agreement
commenced on April 1, 2025, and requires payments of $
| 27 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 9 - COMMITMENTS AND CONTINGENCIES (Continued)
Operating Leases (Continued)
On
January 1, 2025, the Company entered into an amendment in its lease agreement with a third party wherein the Company is the lessee of
certain commercial property. The amendment commenced on January 1, 2025, and
On
March 20, 2025, the Company entered into an amendment in its long-term lease agreement with a related party wherein the Company is the
lessee of certain commercial property. The amendment commenced on April 1, 2025, and
On
February 24, 2026, the Company entered into a renewal lease agreement for office and storage space located in Blanco, Texas. The lease
commenced on March 1, 2026 and expires on
SCHEDULE OF SUPPLEMENTAL BALANCE SHEET INFORMATION LEASE CASH FLOW
| Nine months ended | ||||||||
| Lease cash flow information: | September 30, 2026 | September 30, 2025 | ||||||
| Cash paid for amounts included in the measurement of lease liabilities: | ||||||||
| Operating cash flows from operating leases | $ | $ | ||||||
| Total | $ | $ | ||||||
SCHEDULE OF LEASE RELATED ASSETS AND LIABILITIES
| Summary of lease-related assets and liabilities: | September 30, 2026 | December 31, 2025 | ||||||
| Operating lease right-of-use assets | $ | $ | ||||||
| Accumulated amortization | ( | ) | ( | ) | ||||
| Net operating ROU assets | $ | $ | ||||||
| Current operating liabilities | $ | $ | ||||||
| Noncurrent operating lease liabilities | ||||||||
| Total operating lease liabilities | $ | $ | ||||||
| 28 |
CALLAN JMB INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 9 - COMMITMENTS AND CONTINGENCIES (Continued)
Operating Leases (Continued)
SCHEDULE OF MATURITY LEASE PAYMENTS FOR OPERATING LEASES
| Maturity of lease liabilities | September 30, 2026 (Unaudited) | |||
| October 2026 – September 2027 | $ | |||
| October 2027 – September 2028 | ||||
| October 2028 – September 2029 | ||||
| October 2029 – September 2030 | ||||
| October 2030 – September 2031 | ||||
| Thereafter | ||||
| Total future undiscounted lease payments | ||||
| Less: interest | ( | ) | ||
| Present value of lease liabilities | $ | |||
Legal Proceedings
The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business.
Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.
NOTE 10 – SUBSEQUENT EVENTS
The Company has evaluated subsequent events that occurred after September 30, 2026, through November 13, 2026.
Equity Line of Credit
Subsequent
to September 30, 2026, the Company issued
In
October 2026, the Company also completed an additional $
Nasdaq Delisting Letter
On
October 12, 2026, the Company received a determination letter from Nasdaq stating that the Company had not regained compliance with Nasdaq
Listing Rule 5550(b), which requires, among other alternatives, a minimum of $
Line of Credit
The Company and First United Bank and Trust Co agreed to extend the maturity date of the Line of Credit by 90 days, from October 29, 2026 to January 27, 2027. All other terms of the Line of Credit remain unchanged.
There have been no other events or transactions during this time which would have a material effect on these consolidated financial statements.
Private Investment in Public Equity
On November 10, 2026, the Company entered into a Securities
Purchase Agreement (the “Purchase Agreement”) with certain accredited investors and closed a private investment of
Acquisitions
In August 2026, Callan JMB and its wholly owned subsidiary, Callan Power LLC, entered into two separate proposed acquisition transactions to acquire certain oil and gas leasehold interests and related assets. The Reger Oil agreement was signed on August 19, 2026, but the transaction did not close and was not completed. A second Asset Purchase Agreement (APA) was signed with The Pfanenstiel Company on August 26, 2026. On October 16, 2026, the Company has exercised its right to terminate the APA. As a result of the expiration and termination, neither proposed acquisition transactions were consummated.
NOTE 11 – Revision to June 30, 2026 Condensed Consolidated Financial Statements
During the preparation of the financial statements for the three and nine months ended September 30, 2026, the Company identified some revisions in the previously issued financial statements for the three and six months ended June 30, 2026. The revisions related to costs incurred in connection with a service contract performed for a customer that were previously capitalized as construction in progress rather than expensed as cost of revenue. This item was identified as part of management’s review of the financial results for the three and nine months ended September 30, 2026. The amounts of the revisions to the June 30, 2026 condensed consolidated financial statements were not deemed to be material by management.
The revisions to the six months ended June 30, 2026 consolidated financial statements are as follows:
SCHEDULE OF REVISION TO CONSOLIDATED FINANCIAL STATEMENTS
| Financial Statement Line Item | As Previously Reported | Revisions | As Revised | |||||||||
| Cost of revenue | ||||||||||||
| Gross profit | ( | ) | ||||||||||
| Loss from operations | ( | ) | ( | ) | ( | ) | ||||||
| Net loss | ( | ) | ( | ) | ( | ) | ||||||
| Net loss per share | ( | ) | ( | ) | ||||||||
| Property and equipment, net | ( | ) | ||||||||||
| Total assets | ( | ) | ||||||||||
| Accumulated deficit | ( | ) | ( | ) | ( | ) | ||||||
| Total stockholders’ equity | ( | ) | ||||||||||
| Financial Statement Line Item | As Previously Reported | Revisions | As Revised | |||||||||
| Net cash provided by (used in) investing activity | ( | ) | ||||||||||
| Net cash used in operating activities | ( | ) | ( | ) | ( | ) | ||||||
The revisions to the three months ended June 30, 2026 consolidated financial statements are as follows:
| Financial Statement Line Item | As Previously Reported | Revisions | As Revised | |||||||||
| Cost of revenue | ||||||||||||
| Gross profit | ( | ) | ||||||||||
| Loss from operations | ( | ) | ( | ) | ( | ) | ||||||
| Net loss | ( | ) | ( | ) | ( | ) | ||||||
| Net loss per share | ( | ) | ( | ) | ||||||||
| 29 |
PART II
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis is intended as a review of significant factors affecting our financial condition and results of operations for the periods indicated. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the accompanying notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to “we,” “us,” and “our” refer to Callan JMB Inc.
Forward-Looking Statements
The information in this discussion contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which are subject to the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, statements concerning our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management. The words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in our filings with the SEC. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements
Overview
Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.
Strategy
Our strategy involves leveraging our core competitive strengths to develop and maintain ongoing relationships with a diversified group of customers while continuing to grow our service lines, ensuring that we can meet our customers’ changing needs. We strive to be recognized as the premier provider of logistics and fulfillment of a broad range of value-added services based upon the breadth of those services, quality, responsiveness, customer service, information technologies, safety, and cost effectiveness.
We view our solutions as disruptive to the “older technologies” of dry ice and liquid nitrogen, in that our solutions are comprehensive and combine our competencies in configurations that are customized to our client’s requirements. We provide comprehensive, reliable, economic alternatives to all existing logistics solutions and services utilized for frozen shipping in the life sciences industry (e.g., personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). As part of our services, we provide the ability to monitor, record and archive crucial information for each shipment that can be used for scientific and regulatory purposes.
| 30 |
Seasonality
Based on our industry and our historic trends, we expect our operations to vary seasonally. Typically, revenue will be highest in the third and fourth calendar quarters and lowest in the first and second calendar quarters. These seasonal variations result in fluctuations in waste volumes due to weather conditions and general economic activity. We also expect that our operating expenses may be higher during the winter months due to periodic adverse weather conditions that can slow the collection of waste, resulting in higher labor and operational costs.
Results of Operations
Three and Nine months ended September 30, 2026, Compared to the Three and Nine months ended September 30, 2025
The following table provides certain selected financial information for the periods presented:
| (Unaudited) | ||||||||||||||||
| Three months ended Sep 30, | ||||||||||||||||
| 2026 | 2025 | Change | Change % | |||||||||||||
| Revenue | $ | 1,146,699 | $ | 1,446,917 | $ | (300,218 | ) | -21 | % | |||||||
| Cost of Revenue | 677,531 | 953,610 | (276,079 | ) | -29 | % | ||||||||||
| Gross Profit | $ | 469,168 | $ | 493,307 | $ | (24,139 | ) | -5 | % | |||||||
| Selling, General and administrative expenses | 2,669,722 | 2,372,465 | 297,257 | 13 | % | |||||||||||
| Total operating expenses | $ | 2,669,722 | $ | 2,372,465 | $ | 297,257 | 13 | % | ||||||||
| Income (loss) from operations | $ | (2,200,554 | ) | $ | (1,879,158 | ) | $ | (321,396 | ) | 17 | % | |||||
| Other income (expense) | (446,632 | ) | (852,183 | ) | 405,551 | -48 | % | |||||||||
| Income (loss) before income taxes | $ | (2,647,186 | ) | $ | (2,731,341 | ) | $ | 84,155 | -3 | % | ||||||
| Provision for income taxes | (3,058 | ) | - | (3,058 | ) | 0 | % | |||||||||
| Net income (loss) | $ | (2,644,128 | ) | $ | (2,731,341 | ) | $ | 87,213 | -3 | % | ||||||
| (Unaudited) | ||||||||||||||||
| Nine months ended September 30, | ||||||||||||||||
| 2026 | 2025 | Change | Change % | |||||||||||||
| Revenue | $ | 3,629,167 | $ | 4,562,604 | $ | (933,437 | ) | -20 | % | |||||||
| Cost of Revenue | 2,065,570 | 2,812,334 | (746,764 | ) | -27 | % | ||||||||||
| Gross Profit | $ | 1,563,597 | $ | 1,750,270 | $ | (186,673 | ) | -11 | % | |||||||
| Operating Expenses | $ | - | $ | - | ||||||||||||
| Selling, General and administrative expenses | 6,902,736 | 6,274,343 | 628,393 | 10 | % | |||||||||||
| Total operating expenses | $ | 6,902,736 | $ | 6,274,343 | $ | 628,393 | 10 | % | ||||||||
| Income (loss) from operations | $ | (5,339,139 | ) | $ | (4,524,073 | ) | $ | (815,066 | ) | 18 | % | |||||
| Other income (expense) | (1,840,635 | ) | (847,997 | ) | (992,638 | ) | 117 | % | ||||||||
| Income (loss) before income taxes | $ | (7,179,774 | ) | $ | (5,372,070 | ) | $ | (1,807,704 | ) | 34 | % | |||||
| Provision for income taxes | 2,082 | 1,257 | 825 | 66 | % | |||||||||||
| Net income (loss) | $ | (7,181,856 | ) | $ | (5,373,327 | ) | $ | (1,808,529 | ) | 34 | % | |||||
Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025
Revenue and Cost of Goods Sold
Revenue decreased by $300,218 for the three months ended September 30, 2026, compared to the three months ended September 30, 2025. The decrease was primarily due to a $218,427 decline in product sales and fulfillment services revenue and a $74,465 decline in shipping revenue.
Cost of revenue decreased by $276,079 for the three months ended September 30, 2026, compared to the three months ended September 30, 2025, consistent with the lower revenue volume. The decrease was primarily driven by a $198,891 reduction in freight and shipping costs and a $83,325 reduction in direct labor costs associated with fulfillment services.
Selling, General and Administrative Expenses
Selling, general and administrative (“SG&A”) expenses increased by $297,257 for the three months ended September 30, 2026, compared to the three months ended September 30, 2025. The increase was primarily driven by a $150,000 increase in professional fees, a $89,319 increase in salaries and benefits, a $29,688 increase in public relations and branding expenses and overall increases in travel expenses and legal expenses.
| 31 |
Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025
Revenue and Cost of Goods Sold
Revenue decreased by $933,437 for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025. The decrease was primarily due to a $455,147 decline in government contracts revenue, a $379,366 decline in product sales revenue, and a $119,454 decline in fulfillment revenue, partially offset by a net increase of $20,530 in other revenue.
Cost of revenue decreased by $746,764 for the same period, consistent with the decline in revenue. The decrease was primarily driven by a $327,622 reduction in direct labor costs, a $202,326 reduction in transportation costs, a $120,285 reduction in the cost of medical supplies, and a $79,547 reduction in warehouse supplies and equipment.
Selling, General and Administrative Expenses
Selling, general and administrative (“SG&A”) expenses increased by $628,393 for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025. The increase was primarily driven by a $150,000 increase in professional fees, increases in salaries and benefits of $236,117, an increase in marketing and advertising of $171,650, and insurance expenses of $52,227.
Liquidity and Capital Resources
Our principal liquidity requirements are for working capital to fund our operations and growth. To date, we have funded our liquidity requirements through a combination of cash on hand, cash flows from operations, and funding from various sources, including from the CEO. As of September 30, 2026, we had $1,776,719 cash and cash equivalents.
As of September 30, 2026, the Company had an accumulated deficit of $(17,441,870) and negative cash flow from operating activities of $(3,999,236) for the nine months ended September 30, 2026. In addition, the Company incurred a net loss of $(7,181,856) for the nine months ended September 30, 2026 and had cash and cash equivalents of $1,776,719 as of September 30, 2026. The Company has recurring losses, has not yet generated sufficient cash flows from operations to fund its activities, and expects to continue incurring operating losses and using cash in support of its business plan.
Management’s plans include raising additional capital through sales of common stock under the ELOC Facility and the ATM program, other equity or debt financing, and continued support from our Chief Executive Officer.
Under our ELOC Facility with Hexstone Capital, LLC, as amended and restated on August 18, 2026, we may sell up to $75.0 million of our common stock to the investor through April 1, 2027, subject to the conditions of the purchase agreement. During the nine months ended September 30, 2026, we received gross proceeds of $3.0 million from sales under the ELOC Facility. In October 2026, we completed an additional $4.0 million of sales under the ELOC Facility, resulting in net proceeds of $3.66 million after transaction fees. However, the availability and terms of future financing depend on several factors: market conditions, investor demand, the trading price and volume of our common stock, our continued listing on The Nasdaq Capital Market, and our operating performance. There can be no assurance that additional capital will be available when needed or on acceptable terms.
In addition, on July 29, 2026, the Company entered into a $1.0 million non-revolving line of credit with First United Bank and Trust Co. to fund working capital. CTS drew the full amount during the third quarter, and no further borrowing availability remains. The Line of Credit is secured by substantially all of CTS’s assets and by collateral pledged by, and unlimited guarantees from related parties. It restricts CTS from incurring additional debt or making distributions without the lender’s consent. As of September 30, 2026, CTS was in compliance with all covenants. The Line of Credit originally matured on October 29, 2026. The lender agreed to extend the maturity by 90 days to January 27, 2027, with all other terms unchanged.
In evaluating our ability to meet our obligations as they become due within one year after the date the condensed consolidated financial statements are issued, management considered these conditions, the maturity of the Line of Credit, our cash on hand and our projected operating cash flows. These conditions raise substantial doubt about our ability to continue as a going concern within one year after the date the condensed consolidated financial statements included in this Quarterly Report are issued. Management’s plans have not alleviated that substantial doubt.
| 32 |
On April 7, 2026, the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders’ equity for continued listing on The Nasdaq Capital Market. The Company submitted a compliance plan to Nasdaq and is working to regain compliance; however, there can be no assurance that the Company will regain compliance within any period granted by Nasdaq.
On June 29, 2026, the Company received an additional notice from Nasdaq indicating that it was not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share. The Company has until December 28, 2026 to regain compliance with the minimum bid price requirement. The notices have no immediate effect on the listing of the Company’s common stock, which continues to trade on The Nasdaq Capital Market under the symbol “CJMB.”
On October 12, 2026, the Company received a determination letter from Nasdaq stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(b), which requires, among other alternatives, a minimum of $2.5 million in stockholders’ equity. The Company subsequently appealed Nasdaq’s determination. On October 15, 2026, Nasdaq acknowledged the Company’s appeal and notified the Company that the delisting action had been stayed pending a final written decision by the Nasdaq Hearings Panel. An oral hearing is scheduled for November 17, 2026.
The Company is actively monitoring its compliance with Nasdaq’s continued listing requirements and evaluating alternatives to regain and maintain compliance. There can be no assurance that the Company will regain compliance with the applicable Nasdaq listing standards or otherwise maintain compliance with the continued listing requirements of The Nasdaq Capital Market.
| (Unaudited) | ||||||||||||
| For Nine months Ended | ||||||||||||
| Sep 30, | ||||||||||||
| 2026 | 2025 | Change | ||||||||||
| Cash used in operating activities | $ | (3,999,236 | ) | $ | (3,887,737 | ) | $ | (111,499 | ) | |||
| Cash used in investing activities | (35,312 | ) | (616,896 | ) | 581,584 | |||||||
| Cash provided by financing activities | 3,680,509 | 5,196,432 | (1,515,923 | ) | ||||||||
| Increase (decrease) in cash | $ | (354,039 | ) | $ | 691,799 | $ | (1,045,838 | ) | ||||
Cash used in operating activities
For the nine months ended September 30, 2026, cash used in operating activities was $(3,999,236) compared to $(3,887,737) during the nine months ended September 30, 2025, an increase in cash used of $111,499. The increase was primarily due to the increase in net loss of $1,808,529, partially offset by higher non-cash charges, including $1,368,662 of ELOC-related expenses settled in shares of common stock and $129,499 of common stock issued for professional services, and by a $813,228 favorable change in working capital.
Cash used in investing activities
For the nine months ended September 30, 2026, cash used in investing activities was $(35,312) compared to $(616,896) for the nine months ended September 30, 2025, a decrease of $581,584. The decrease is a result of the leasehold improvements made to the new corporate office during the nine months ended September 30, 2025, which did not recur in 2026.
Cash provided by financing activities
During the nine months ended September 30, 2026, cash provided by financing activities was $3,680,509 compared to $5,196,432 during the nine months ended September 30, 2025, a decrease of $1,515,923. The decrease was primarily due to the Company’s initial public offering in 2025, which generated net proceeds of $4,543,988. Financing activities for the nine months ended September 30, 2026 consisted of $2,815,000 of net proceeds from the issuance of shares under the ELOC Facility and $1,000,000 of borrowings under the line of credit, partially offset by $75,000 of deferred offering costs related to the ATM program and $59,491 of advances to an affiliate.
Off-Balance Sheet Arrangements
We have no off-balance sheet financing arrangements.
| 33 |
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Under SEC rules and regulations, because we are considered to be a “smaller reporting company,” we are not required to provide the information required by this item in this report.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 30, 2026, to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the SEC, including to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of September 30, 2026, our disclosure controls and procedures were not effective. Management identified a material weakness on the timeliness and consistency of execution of oversight reviews and governance impacting the performance of certain internal control activities, which affected the Company’s ability to consistently achieve its control objectives. During the year ended December 31, 2025, the Company continued to develop and refine its disclosure controls and other procedures designed to ensure that information required to be disclosed in reports filed with the SEC is recorded, processed, summarized, and reported within the time periods specified by SEC rules and forms. In response to the identified ineffectiveness of controls, management has worked on enhancing oversight and governance processes, improving documentation of accounting policies and procedures, and engaged experienced third-party advisors to support GAAP compliance and financial reporting. While progress was made during the year ended December 31, 2025 and has continued through the nine months ended September 30, 2026, remediation of the material weakness will not be considered complete until the redesigned controls have operated effectively for a sustained period and have been validated through testing.
| (b) | Changes in Internal Controls Over Financial Reporting |
There were no changes in our internal controls over financial reporting that occurred during the last fiscal quarter covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
| 34 |
PART II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
During the nine months ended September 30, 2026, the Company finalized a settlement with its former executive related to previously existing claims with no financial impact. There currently is no material pending legal proceeding to which we are a party or to which any of our property is subject, and our management is not aware of any contemplated proceeding by any governmental authority against us. From time to time, we may become involved in legal proceedings or subject to claims incident to the ordinary course of business. Regardless of outcome, such proceedings or claims can have an adverse impact on us because of defense and settlement costs, diversion of resources, negative publicity, reputational harm, and other factors and there can be no assurances that favorable outcomes will be obtained.
ITEM 1A. RISK FACTORS
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Recent Sale of Unregistered Equity Securities
During the three and nine months ended September 30, 2026 no unregistered sales of equity securities occurred.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
| 35 |
ITEM 6. EXHIBITS
| Exhibit | ||
| Number | Description | |
| 3.1 | Callan JMB Inc. Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Registrant’s Registration Statement on Form S-1,as amended (File No. 333-282879), filed with the SEC on January 8, 2025) | |
| 3.2 | Bylaws, adopted on February 2, 2024 (incorporated by reference to Exhibit 3.2 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-282879), filed with the SEC on January 8, 2025) | |
| 10.1 | Form of Equity Purchase Agreement, dated July 24, 2025, by and between Callan JMB Inc. and the Investor (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K (File No. 001-42506) filed with the SEC on July 25, 2025) | |
| 10.2 | Form of Registration Rights Agreement, dated July 24, 2025, by and between Callan JMB Inc. and the Investor (incorporated by reference to Exhibit 10.2 of the Registrant’s Current Report on Form 8-K (File No. 001-42506) filed with the SEC on July 25, 2025) | |
| 10.3 | Standard Sublease Agreement, dated October 1, 2024, by and between lessor and Callan JMB, Inc. | |
| 10.4 | Standard Lease Agreement, dated April 1, 2025, by and between Outlaw Run Ranch, LLC. and Coldchain Technology Services, LLC | |
| 31.1* | Certification of Co-Chief Executive Officers (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 31.2* | Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 32.1** | Certification of Co-Chief Executive Officers (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 32.2** | Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 101.INS | Inline XBRL Instance Document | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
| * | Filed herewith. |
| ** | Furnished herewith. |
| 36 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CALLAN JMB INC. | ||
| By: | /s/ Wayne Williams | |
| Wayne Williams | ||
| Chief Executive Officer, President, and Chairman of the Board | ||
| SIGNATURE | TITLE | DATE | ||
| /s/ Wayne Williams | Chief Executive Officer, President | November 13, 2026 | ||
| Wayne Williams | (Principal Executive Officer) and Chairman of the Board | |||
| /s/ Christopher Shields | Interim Chief Financial Officer | November 13, 2026 | ||
| Christopher Shields | (Principal Financial and Accounting Officer) |
| 37 |